-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Integrated Biopharma Inc quarterly/annual Operating Lease, Payments history and growth rate from Q3 2018 to Q3 2024.
- Integrated Biopharma Inc Operating Lease, Payments for the quarter ending September 30, 2024 was $236K, a 10.9% decline year-over-year.
- Integrated Biopharma Inc annual Operating Lease, Payments for 2024 was $1.06M, a 7.28% increase from 2023.
- Integrated Biopharma Inc annual Operating Lease, Payments for 2023 was $989K, a 52.2% increase from 2022.
- Integrated Biopharma Inc annual Operating Lease, Payments for 2022 was $650K, a 2.11% decline from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)